FDA Approves Expanded Indication for Tenofovir Alafenamide as Hepatitis B Treatment
The new indication includes pediatric patients aged 6 years and older who weigh at least 25 kg and have compensated liver disease.
Source: pharmacytimes.com
Stay updated with breaking news from Krek School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new indication includes pediatric patients aged 6 years and older who weigh at least 25 kg and have compensated liver disease.